Filing Details
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2009-04-23 10:19:52
- Reporting Period:
- 2008-03-20
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 94784 | Alseres Pharmaceuticals Inc | ALSE | () |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 904389 | L Robert Gipson | C/O Ingalls &Amp; Snyder Llc 61 Broadway New York NY 10006 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2008-11-20 | 543,478 | $1.84 | 5,649,482 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
